A biotechnology company focused on cancer immunotherapy. It was founded in 2007 and is based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
Vaxil Bio therapeutics is anA Israelibiotechnology biotechcompany focused on cancer immunotherapyimmunotherapy,. It was founded in 2007 and is based in the Weizmann Science Park in RehovotRehovot, IsraelIsrael. Vaxil is listed on the TSX-Venture TSX-Venture as VXL
Vaxil Bio Therapeutics is an Israel-based immuno-oncology biotechnology company specializing in cancer and infectious diseases. It conducts research and development of medical solutions for its studied illnesses. Its lead product, IMMUCIN, is for immunotherapy purposes and has been given orphan drug status from both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
In 2020, the company utilized its VaxHit bioinformatics platform to create a vaccine candidate for COVID-19 using signal peptide technology. The candidate's design has been successful in testing a tuberculosis vaccine.
Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
A biotechnology company focused on cancer immunotherapy. It was founded in 2007 and is based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
Company